USANA Health Sciences (USNA) Tops Q3 EPS by 19c, Updates FY Guidance
Get Alerts USNA Hot Sheet
Price: $43.14 -1.28%
Revenue Growth %: -9.9%
Financial Fact:
Income taxes: 6M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -9.9%
Financial Fact:
Income taxes: 6M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.44, $0.19 better than the analyst estimate of $1.25. Revenue for the quarter came in at $298.5 million versus the consensus estimate of $277.26 million.
GUIDANCE:
USANA Health Sciences sees FY2020 EPS of $5.15-$5.45, versus the consensus of $5.18. USANA Health Sciences sees FY2020 revenue of $1.09-1.115 billion, versus the consensus of $1.08 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Utah Medical Products (UTMD) Reports Q1 EPS of $1.10
- Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!